Insulin sensitivity in women: A comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting

European Journal of Endocrinology

Volumn 145, Issue 3, 2001, Pages 281-287

  Cagnacci, A ^a   Arangino, S ^a   Renzi, A ^a   Cagnacci, P ^a   Volpe, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GOSERELIN; INSULIN; TIBOLONE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; FOLLICULAR PHASE; HUMAN; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; INTRAVENOUS GLUCOSE TOLERANCE TEST; MENSTRUAL CYCLE; METHODOLOGY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SAMPLING;

EID: 0034850937     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450281     Document Type: Article

References (38)

1. Insulin resistance and the polycystic ovary syndrome: Mechanisms and implications for pathogenesis
2. Insulin resistance: Syndrome or tendency?
3. Hyperinsulinemia as an independent risk factor for ischemic heart disease
4. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance
5. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM
6. Insulin sensitivity and intake of vitamins E and C in African. American, Hispanic, and non-Hispanic white men and women: The Insulin Resistance and Atherosclerosis Study (IRAS)
7. Insulin resistance in obese and nonobese man
8. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?
9. Fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
10. A simple measure of insulin resistance
11. FIRI: A fair insulin resistance index?
12. Efficacy of troglitazone measured by insulin resistance index
13. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
14. A prospective analysis of the HOMA model. The Mexico City Diabetes Study
15. The homeostasis model in the San Antonio Heart Study
16. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose load state
17. Quantitative insulin sensitivity check index: A simple, accurate method of assessing insulin sensitivity in humans
18. Carbohydrate homeostasis
19. Insulin release and peripheral sensitivity at the oral glucose tolerance test
20. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose and FFA levels
21. Insulin sensitivity indices obtained from oral glucose tolerance testing
22. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp
23. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects
24. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
25. Effect of tibolone on glucose and lipid metabolism in postmenopausal women
26. The effect of transdermal 17β-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration
27. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
28. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweden Monica population study
29. Estimates of in vivo insulin action in humans: Comparison of the insulin clamp and the minimal model techniques
30. Non-insulin mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis
31. Is the minimal model too minimal?
32. Reassessment of glucose effectiveness and insulin sensitivity from minimal model method analysis: A theoretical evaluation of the single-compartment glucose distribution assumption
33. Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness
34. Estimates of insulin action in normal, obese and NIDDM man: Comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques
35. Reduced sample number for calculations of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies
36. Repeatibility of insulin sensitivity and glucose effectiveness from the minimal model method. Implications for study design
37. The glucagon-like peptides